Market Cap 53.78M
Revenue (ttm) 19.65M
Net Income (ttm) -7.57M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -38.52%
Debt to Equity Ratio -0.51
Volume 417,000
Avg Vol 651,080
Day's Range N/A - N/A
Shares Out 31.82M
Stochastic %K 6%
Beta 1.17
Analysts Strong Sell
Price Target $5.12

Company Profile

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in...

Industry: Medical Devices
Sector: Healthcare
Phone: 972 499 4934
Address:
2515 McKinney Avenue, Suite 1000, Dallas, United States
twighttrades1
twighttrades1 Jul. 17 at 12:40 AM
$MDAI - im still buying this- im patiently expecting this to release nor stuff getting the tutes to load- happy to wait- interesting and straight forward play-
0 · Reply
Jwex2012
Jwex2012 Jul. 16 at 6:07 PM
$MDAI I hope management remembers there is a quarterly due. They seem to be a little distracted from running the company.
1 · Reply
afterhoursearnings
afterhoursearnings Jul. 16 at 12:51 PM
$MDAI 2.3 mil shares short with 16 days to cover at current volume lull, may be worth tapping the ask a little.
0 · Reply
afterhoursearnings
afterhoursearnings Jul. 16 at 12:49 PM
$MDAI then the order gets pulled back again, interesting
0 · Reply
afterhoursearnings
afterhoursearnings Jul. 16 at 12:17 PM
$MDAI someone trying to sell those 1.7k shares real bad this morning, couple price drops already
0 · Reply
afterhoursearnings
afterhoursearnings Jul. 16 at 11:56 AM
$MDAI good morning everyone
0 · Reply
SeanIsTheBest
SeanIsTheBest Jul. 15 at 3:35 PM
$MDAI Right now the price action is very similar to 11/20/2025 ~ 03/18/2026. Market maker/Big player is trying to build base here, and it surely will dip to a new low before any big announcements just like 03/13/2026~03/18/2026. My guess is 1.49~1.55. If commercialization goes well and they deliver something beyond expectations, it has chance to challenge $3 again. If your price target is $10+, lol good luck realistically you will need to wait at least 2 years based on company's slow vide. If your price target is $4~$6, well this year is impossible. I would say earliest Q2 2027 is the time range you are looking for if they are able to sign at least one contract with hospitals. If your target is $3, watch out this year Q4, but remember it would ONLY happen when they exceed their goals. Barda 30 units deployment is not enough. If they announce something like 'we successfully deploy 30 units', maximum 2.5~2.8 and sell off. This is plan for anyone who looks for exit to run money wisely
1 · Reply
ChubbyDave
ChubbyDave Jul. 15 at 2:21 AM
$MDAI the churn down is happening again, still waiting for my 1.50s… I’ve got powder and I ain’t afraid to use it
1 · Reply
Dexter2025
Dexter2025 Jul. 14 at 10:13 PM
$MDAI Wow, what’s happening now? Some news? Who knows?
1 · Reply
afterhoursearnings
afterhoursearnings Jul. 14 at 6:41 PM
$MDAI couldn't disagree more, historically this thing moves news or not. Folks are waiting to see if selling has exhausted or we get a spring move to go in heavy. 1-3 quite a few times now.
1 · Reply
Latest News on MDAI
Spectral AI names Darcy Bajko chief commercial officer

2026-07-08T13:15:22.000Z - 8 days ago

Spectral AI names Darcy Bajko chief commercial officer


Spectral AI price target raised to $4 from $3 at BTIG

2026-05-26T23:15:07.000Z - 7 weeks ago

Spectral AI price target raised to $4 from $3 at BTIG


Spectral AI Earnings Call Transcript: Q1 2026

May 12, 2026, 5:00 PM EDT - 2 months ago

Spectral AI Earnings Call Transcript: Q1 2026


Spectral AI Earnings release: Q1 2026

May 12, 2026, 5:00 PM EDT - 2 months ago

Spectral AI Earnings release: Q1 2026


Spectral AI Quarterly report: Q1 2026

May 12, 2026, 5:00 PM EDT - 2 months ago

Spectral AI Quarterly report: Q1 2026


Spectral AI Announces 2026 First Quarter Financial Results

May 12, 2026, 4:10 PM EDT - 2 months ago

Spectral AI Announces 2026 First Quarter Financial Results


Spectral AI Announces Annual Meeting of Stockholders

Apr 20, 2026, 4:15 PM EDT - 3 months ago

Spectral AI Announces Annual Meeting of Stockholders


Spectral AI Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 3 months ago

Spectral AI Proxy statement: Proxy filing


Spectral AI Proxy statement: Proxy filing

Apr 16, 2026, 8:00 AM EDT - 3 months ago

Spectral AI Proxy statement: Proxy filing


Spectral AI appoints David McGuire as CFO

2026-04-08T13:01:46.000Z - 3 months ago

Spectral AI appoints David McGuire as CFO


Spectral AI Proxy statement: Proxy filing

Apr 6, 2026, 8:00 AM EDT - 3 months ago

Spectral AI Proxy statement: Proxy filing


Spectral AI Earnings Call Transcript: Q4 2025

Mar 24, 2026, 5:00 PM EDT - 4 months ago

Spectral AI Earnings Call Transcript: Q4 2025


Spectral AI Annual report: Q4 2025

Mar 24, 2026, 5:00 PM EDT - 4 months ago

Spectral AI Annual report: Q4 2025


Spectral AI Earnings release: Q4 2025

Mar 24, 2026, 5:00 PM EDT - 4 months ago

Spectral AI Earnings release: Q4 2025


Spectral AI reports Q4 EPS 2c with items, consensus (14c)

2026-03-24T20:30:43.000Z - 4 months ago

Spectral AI reports Q4 EPS 2c with items, consensus (14c)


Spectral AI sees FY26 revenue $18.5M, consensus $14.08M

2026-03-24T20:30:33.000Z - 4 months ago

Spectral AI sees FY26 revenue $18.5M, consensus $14.08M


Spectral AI appoints Capone as CEO

2026-02-10T13:36:41.000Z - 5 months ago

Spectral AI appoints Capone as CEO


Spectral AI Names Vincent S. Capone as Chief Executive Officer

Feb 10, 2026, 8:30 AM EST - 5 months ago

Spectral AI Names Vincent S. Capone as Chief Executive Officer


DeepView™ System Featured at 2025 US Burn Conferences

Nov 19, 2025, 8:00 AM EST - 8 months ago

DeepView™ System Featured at 2025 US Burn Conferences


Spectral AI Earnings Call Transcript: Q3 2025

Nov 11, 2025, 5:00 PM EST - 8 months ago

Spectral AI Earnings Call Transcript: Q3 2025


Spectral AI Quarterly report: Q3 2025

Nov 11, 2025, 5:00 PM EST - 8 months ago

Spectral AI Quarterly report: Q3 2025


Spectral AI Earnings release: Q3 2025

Nov 11, 2025, 5:00 PM EST - 8 months ago

Spectral AI Earnings release: Q3 2025


Spectral AI reports Q3 EPS (13c), consensus (9c)

2025-11-11T21:05:49.000Z - 8 months ago

Spectral AI reports Q3 EPS (13c), consensus (9c)


Spectral AI Announces 2025 Third Quarter Financial Results

Nov 11, 2025, 4:00 PM EST - 8 months ago

Spectral AI Announces 2025 Third Quarter Financial Results


Spectral AI Registration statement: Registration Filing

Oct 30, 2025, 8:00 AM EDT - 9 months ago

Spectral AI Registration statement: Registration Filing


Spectral AI prices 4M shares at $1.90 in offering

2025-10-23T12:35:29.000Z - 9 months ago

Spectral AI prices 4M shares at $1.90 in offering


Spectral AI raises $7.6 Million of Additional Growth Capital

Oct 23, 2025, 8:30 AM EDT - 9 months ago

Spectral AI raises $7.6 Million of Additional Growth Capital


Spectral AI Earnings Call Transcript: Q2 2025

Aug 12, 2025, 5:00 PM EDT - 1 year ago

Spectral AI Earnings Call Transcript: Q2 2025


Spectral AI Quarterly report: Q2 2025

Aug 12, 2025, 5:00 PM EDT - 1 year ago

Spectral AI Quarterly report: Q2 2025


Spectral AI Earnings release: Q2 2025

Aug 12, 2025, 5:00 PM EDT - 1 year ago

Spectral AI Earnings release: Q2 2025


Spectral AI reports Q2 EPS (31c) vs. (16c) last year

2025-08-12T20:06:31.000Z - 1 year ago

Spectral AI reports Q2 EPS (31c) vs. (16c) last year


Spectral AI Announces 2025 Second Quarter Financial Results

Aug 12, 2025, 4:00 PM EDT - 1 year ago

Spectral AI Announces 2025 Second Quarter Financial Results


Spectral AI appoints Stanley Micek as COO

2025-05-30T12:05:22.000Z - 1 year ago

Spectral AI appoints Stanley Micek as COO


Spectral AI Earnings Call Transcript: Q1 2025

May 13, 2025, 5:00 PM EDT - 1 year ago

Spectral AI Earnings Call Transcript: Q1 2025


Spectral AI Quarterly report: Q1 2025

May 13, 2025, 5:00 PM EDT - 1 year ago

Spectral AI Quarterly report: Q1 2025


Spectral AI Earnings release: Q1 2025

May 13, 2025, 5:00 PM EDT - 1 year ago

Spectral AI Earnings release: Q1 2025


Spectral AI Announces 2025 First Quarter Financial Results

May 13, 2025, 4:05 PM EDT - 1 year ago

Spectral AI Announces 2025 First Quarter Financial Results


Spectral AI Registration statement: Registration Filing

May 7, 2025, 8:00 AM EDT - 1 year ago

Spectral AI Registration statement: Registration Filing


Spectral AI Registration statement: Registration Filing

May 2, 2025, 8:00 AM EDT - 1 year ago

Spectral AI Registration statement: Registration Filing


Spectral AI Registration statement: Registration Filing

Apr 25, 2025, 8:00 AM EDT - 1 year ago

Spectral AI Registration statement: Registration Filing


Spectral AI Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Spectral AI Proxy statement: Proxy Filing


Spectral AI Proxy statement: Proxy Filing

Apr 17, 2025, 8:00 AM EDT - 1 year ago

Spectral AI Proxy statement: Proxy Filing


Spectral AI Earnings Call Transcript: Q4 2024

Mar 27, 2025, 5:00 PM EDT - 1 year ago

Spectral AI Earnings Call Transcript: Q4 2024


Spectral AI Annual report: Q4 2024

Mar 27, 2025, 5:00 PM EDT - 1 year ago

Spectral AI Annual report: Q4 2024


Spectral AI Earnings release: Q4 2024

Mar 27, 2025, 5:00 PM EDT - 1 year ago

Spectral AI Earnings release: Q4 2024


Spectral AI Completes Three Device Installations in Australia

Mar 6, 2025, 10:36 AM EST - 1 year ago

Spectral AI Completes Three Device Installations in Australia


Spectral AI Provides Update to Investors

Jan 22, 2025, 8:00 AM EST - 1 year ago

Spectral AI Provides Update to Investors


Spectral AI Announces Repricing of its Public Warrants

Nov 26, 2024, 10:17 AM EST - 1 year ago

Spectral AI Announces Repricing of its Public Warrants


Spectral AI Registration statement: Registration Filing

Nov 21, 2024, 7:00 AM EST - 1 year ago

Spectral AI Registration statement: Registration Filing


Spectral AI Earnings Call Transcript: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Spectral AI Earnings Call Transcript: Q3 2024


Spectral AI Quarterly report: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Spectral AI Quarterly report: Q3 2024


Spectral AI Earnings release: Q3 2024

Nov 6, 2024, 5:00 PM EST - 1 year ago

Spectral AI Earnings release: Q3 2024


Spectral AI Announces 2024 Third Quarter Financial Results

Nov 6, 2024, 4:05 PM EST - 1 year ago

Spectral AI Announces 2024 Third Quarter Financial Results


twighttrades1
twighttrades1 Jul. 17 at 12:40 AM
$MDAI - im still buying this- im patiently expecting this to release nor stuff getting the tutes to load- happy to wait- interesting and straight forward play-
0 · Reply
Jwex2012
Jwex2012 Jul. 16 at 6:07 PM
$MDAI I hope management remembers there is a quarterly due. They seem to be a little distracted from running the company.
1 · Reply
afterhoursearnings
afterhoursearnings Jul. 16 at 12:51 PM
$MDAI 2.3 mil shares short with 16 days to cover at current volume lull, may be worth tapping the ask a little.
0 · Reply
afterhoursearnings
afterhoursearnings Jul. 16 at 12:49 PM
$MDAI then the order gets pulled back again, interesting
0 · Reply
afterhoursearnings
afterhoursearnings Jul. 16 at 12:17 PM
$MDAI someone trying to sell those 1.7k shares real bad this morning, couple price drops already
0 · Reply
afterhoursearnings
afterhoursearnings Jul. 16 at 11:56 AM
$MDAI good morning everyone
0 · Reply
SeanIsTheBest
SeanIsTheBest Jul. 15 at 3:35 PM
$MDAI Right now the price action is very similar to 11/20/2025 ~ 03/18/2026. Market maker/Big player is trying to build base here, and it surely will dip to a new low before any big announcements just like 03/13/2026~03/18/2026. My guess is 1.49~1.55. If commercialization goes well and they deliver something beyond expectations, it has chance to challenge $3 again. If your price target is $10+, lol good luck realistically you will need to wait at least 2 years based on company's slow vide. If your price target is $4~$6, well this year is impossible. I would say earliest Q2 2027 is the time range you are looking for if they are able to sign at least one contract with hospitals. If your target is $3, watch out this year Q4, but remember it would ONLY happen when they exceed their goals. Barda 30 units deployment is not enough. If they announce something like 'we successfully deploy 30 units', maximum 2.5~2.8 and sell off. This is plan for anyone who looks for exit to run money wisely
1 · Reply
ChubbyDave
ChubbyDave Jul. 15 at 2:21 AM
$MDAI the churn down is happening again, still waiting for my 1.50s… I’ve got powder and I ain’t afraid to use it
1 · Reply
Dexter2025
Dexter2025 Jul. 14 at 10:13 PM
$MDAI Wow, what’s happening now? Some news? Who knows?
1 · Reply
afterhoursearnings
afterhoursearnings Jul. 14 at 6:41 PM
$MDAI couldn't disagree more, historically this thing moves news or not. Folks are waiting to see if selling has exhausted or we get a spring move to go in heavy. 1-3 quite a few times now.
1 · Reply
Dexter2025
Dexter2025 Jul. 14 at 6:35 PM
$MDAI Today’s low trade volume tells me there is no new information, yet. This thing will just sit still, regardless of 2026 year end forecasts, or next year’s. Fund groups will not act on this without specific positive sales reports. Values will jump when they get on board. Those of us holding shares now can either wait it out or move on. I’m patient enough to hold on and ignore daily low volume fluctuations and speculative jibber gabber. Good times will come.
0 · Reply
CorbettCM
CorbettCM Jul. 14 at 5:51 PM
$MDAI Your last point is part of the sales pitch here. Right now in burn and wound care, there is a lot of friction between hospitals and insurance companies because it is difficult to be objective about required treatment up front. Deepview can change this dynamic by giving the hospitals quantifiable data to take to insurance. This should speed up the process and reduces inpatient wait time.
0 · Reply
thA_bAd9
thA_bAd9 Jul. 14 at 5:03 PM
$MDAI I should mention, in investing time is money. Don’t think all this nonsense currently diminishes the end result on this investment, although it could. I do think it is going to cost a lot of wasted time, which to me does mean money.
0 · Reply
thA_bAd9
thA_bAd9 Jul. 14 at 4:59 PM
$MDAI I think some of the AI information posted in regards to sales preparations somewhat help make my previous post. Been investing and researching in this sector a long time. Insurance payment arrangements and financial benefits of new technologies can typically be worked out prior to FDA approvals. As a matter of course they SHOULD be worked out prior to approval application submission. Once FDA gives the green light, the playbook can already be in place. Approval followed by 6 weeks of silence and then finally announcement of a CCO, who is coming from outside the company, so therefore hasn’t had any involvement in developing the playbook, speaks to a lack of preparation IMO. I believe in the product, believe in the company, but believe investors are getting hammered by price action manipulated by a toxic hedge fund currently. This setup was only available to HBC because they were able to access inside information and saw this weakness prior to funding MDAI
1 · Reply
pi828
pi828 Jul. 14 at 4:26 PM
$MDAI I asked Gemini AI about Deepview SaaS sales pricing. It said 3000 to 4000 dollars lease a month. Also, about 5 k dollars usage revenue. Therefore, about a 100k dollars per year per machine. It estimated 5% churn rate. For this to work they need reimbursement codes from all the insurance companies and not use the hospitals general funds.
0 · Reply
cryptobythelake
cryptobythelake Jul. 14 at 1:47 PM
$MDAI More from the GPT assessment: On the other hand, there are reasons not to conclude the company is unprepared just yet: FDA approval does not automatically trigger immediate sales. Hospitals generally don't purchase a new diagnostic technology overnight. Procurement committees, reimbursement considerations, physician training, and integration into clinical workflows can take months. Some commercial discussions cannot be announced. Companies are often negotiating with hospital systems or government agencies under confidentiality agreements. The absence of press releases doesn't necessarily mean nothing is happening. The first meaningful revenue often lags approval. Many medical device companies experience a gap between approval and reported commercial traction.
0 · Reply
cryptobythelake
cryptobythelake Jul. 14 at 1:44 PM
$MDAI Is this a fair assessment of Spectral AI, or a bit premature? This is just the summary of longer answer from Chat GPT. So I'd characterize your assessment this way: "It's probably premature to conclude Spectral AI is unprepared, but it's entirely reasonable to expect investors to see tangible evidence that commercialization planning was underway before FDA approval. If the company fails to announce customer placements, strategic partnerships, or early revenue opportunities over the next several quarters, concerns about commercial execution would become increasingly justified." In other words, I think your concern is reasonable, but the stronger conclusion—that management wasn't prepared to sell the product—still needs more evidence. The next few earnings calls and commercial updates will likely tell investors much more than the FDA approval itself.
0 · Reply
TrickieDickie
TrickieDickie Jul. 14 at 6:59 AM
$MDAI seemingly so under prepared, mismanaged, no plan, no order book, running out of cash, assume a takeover the best option
1 · Reply
thA_bAd9
thA_bAd9 Jul. 13 at 7:56 PM
$MDAI time for the company leadership to get in gear and announce some placements with revenue attached. After some research I’m not a fan of the new CCO hire, I believe they should have gone for someone with better credentials and exposure at a higher level. Right now this is looking like a company that was not well prepared to sell and profit from the product they’ve been working on for the past decade. I guess I was expecting to hear placements being announced almost simultaneously with the FDA approval. Seeming like nobody had that on the list of projects to be working on and the approval was their end game
2 · Reply
TENDIEMAN12
TENDIEMAN12 Jul. 13 at 7:25 PM
$MDAI Short interest decreased to 2,317,435 as of 30/6.
2 · Reply
Dezdood
Dezdood Jul. 13 at 5:38 PM
$MDAI crack on
0 · Reply
pi828
pi828 Jul. 13 at 4:41 PM
$MDAI are we likely to raise money? Since, FDA approval the stock has headed straight down. The CEO had said in the YouTube video no need to raise capital if spending below a million dollars a month. I think he changed his mind.
1 · Reply